Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Scheuring

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
FEBS Letters|September 5, 2001
Two-dimensional crystals: a powerful approach to assess structure, function and dynamics of membrane proteinsH Stahlberg, D Fotiadis, S Scheuring, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Complete sequencing and messenger ribonucleic acid expression analysis of the MEN I gene in adrenal cancerK M Schulte, M Mengel, M Heinze, et al.
Journal of Molecular Biology|September 21, 2001
Mammalian cells express two VPS4 proteins both of which are involved in intracellular protein traffickingS Scheuring, R A Röhricht, B Schöning-Burkhardt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2006
Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP-1) and its inhibitor (TIMP-1) in DCM patientsF Picard, M Brehm, M Fassbach, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteinsS Brisse, D Milatovic, A C Fluit, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory seasonM E Jones, D F Sahm, N Martin, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureusM Boos, S Mayer, A Fischer, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolonesS Brisse, A C Fluit, U Wagner, et al.
DNA and Cell Biology|April 21, 2001
Sequence, organization, chromosomal localization, and alternative splicing of the human serine protease inhibitor gene hurpin (PI13) which is upregulated in psoriasisH F Abts, T Welss, S Scheuring, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolatesF J Schmitz, A C Fluit, D Hafner, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
FEBS Letters|September 5, 2001
Two-dimensional crystals: a powerful approach to assess structure, function and dynamics of membrane proteinsH Stahlberg, D Fotiadis, S Scheuring, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Complete sequencing and messenger ribonucleic acid expression analysis of the MEN I gene in adrenal cancerK M Schulte, M Mengel, M Heinze, et al.
Journal of Molecular Biology|September 21, 2001
Mammalian cells express two VPS4 proteins both of which are involved in intracellular protein traffickingS Scheuring, R A Röhricht, B Schöning-Burkhardt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2006
Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP-1) and its inhibitor (TIMP-1) in DCM patientsF Picard, M Brehm, M Fassbach, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteinsS Brisse, D Milatovic, A C Fluit, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory seasonM E Jones, D F Sahm, N Martin, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureusM Boos, S Mayer, A Fischer, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolonesS Brisse, A C Fluit, U Wagner, et al.
DNA and Cell Biology|April 21, 2001
Sequence, organization, chromosomal localization, and alternative splicing of the human serine protease inhibitor gene hurpin (PI13) which is upregulated in psoriasisH F Abts, T Welss, S Scheuring, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolatesF J Schmitz, A C Fluit, D Hafner, et al.
Pageof 3